Merck & Co., Inc. (BCBA:MRK)

Argentina flag Argentina · Delayed Price · Currency is ARS
30,660
-380 (-1.22%)
At close: Dec 4, 2025
36.27%
Market Cap 362.55T
Revenue (ttm) 88.03T
Net Income (ttm) 26.09T
Shares Out n/a
EPS (ttm) 10,355.40
PE Ratio 13.90
Forward PE 11.25
Dividend 493.24 (1.61%)
Ex-Dividend Date Sep 15, 2025
Volume 1,397
Average Volume 5,334
Open 31,320
Previous Close 31,040
Day's Range 30,440 - 31,320
52-Week Range 16,950 - 32,380
Beta 0.32
RSI 59.41
Earnings Date Feb 3, 2026

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. The company offers human health pharmaceutical for various areas under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. It also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, B... [Read more]

Sector Healthcare
Founded 1891
Employees 75,000
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol MRK
Full Company Profile

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD Financial Statements

News

There is no news available yet.